NAD deficiency perturbs embryonic development resulting in multiple congenital malformations, collectively termed Congenital NAD Deficiency Disorder (CNDD). The authors report fundamental findings ...

In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other medical technology stocks. The MedTech sector is crucial in healthcare, which ...

As it happens, Bruker issued 9.5% more new shares over the last year. That means its earnings are split among a greater number of shares. Per share metrics like EPS help us understand how much ...

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

Bruker (BRKR) reported $979.6 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 14.6%. EPS of $0.76 for the same period compares to $0.70 a year ago.

Stained hearts were scanned using a Skyscan 1272 scanner (Bruker Corporation, Billerica, USA) at a resolution of 1092×1632 with a voltage of 80 kV and a 125 µA current. The filter was set to Al 1 mm ...

Two best in class imaging technologies, combined in one instrument. This complete solution was designed with the researcher in mind to offer unlimited possibilities for in vivo preclinical imaging ...

Bone samples were rotated around their long axes and images were acquired using a Bruker Skyscan 1176 (Bruker, Kontich, Belgium) with the following parameters: pixel size = 9 μm 3; peak tube potential ...

The innovative flexible acquisition geometry of the SKYSCAN 1272 scanner is particularly advantageous over intermediate resolution levels, where scans are several times faster (to obtain the same ...